Generative AI Microservices for Virtual Screening

NVIDIA2024-03-19

NVIDIA

522 views|5 months ago

💫 Short Summary

Nvidia introduces MIM technology for rapid molecule generation and screening in drug discovery, connecting to custom applications to optimize desired properties. The technology generates high-quality drug-like molecules through physics-based simulations, increasing the success rate of medicine development. Biion Nimo's OnDemand microservices revolutionize drug discovery with denovo protein design and guided molecule generation for virtual screening.

✨ Highlights

📊 Transcript

✦

Nvidia Bemo Nims introduces new generative screening paradigm for drug discovery.

00:31

The MIM technology enables rapid molecule generation and screening in minutes.

MIM connects to custom applications to optimize for desired properties, revolutionizing drug development process.

By using physics-based simulations, MIM generates high-quality drug-like molecules that bind to target proteins efficiently.

Biion Nimo is transforming drug discovery with OnDemand microservices for powerful drug discovery workflows, supporting denovo protein design and guided molecule generation for virtual screening.